Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Characterization of anticancer drug resistance by reverse-phase protein array: new targets and strategies

Published:2022-02-01 Issue:2 Volume:19 Page:115-129
ISSN:1478-9450
Container-title:Expert Review of Proteomics
language:en
Short-container-title:Expert Review of Proteomics

Author:

Cathcart Ann M.¹²^ORCID,Smith Hannah¹,Labrie Marilyne¹³,Mills Gordon B.¹

Affiliation:

1. Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

2. Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland, OR, USA

3. Department of Immunology and Cellular Biology, Université de Sherbrooke, Sherbrooke, QC, Canada

Funder

Miriam and Sheldon Adelson Medical Research Foundation

Publisher

Informa UK Limited

Subject

Molecular Biology,Biochemistry

Link

https://www.tandfonline.com/doi/pdf/10.1080/14789450.2022.2070065

Reference151 articles.

1. A view on drug resistance in cancer

2. Assessment of Overall Survival, Quality of Life, and Safety Benefits Associated With New Cancer Medicines

3. Unintended Consequences of Expensive Cancer Therapeutics—The Pursuit of Marginal Indications and a Me-Too Mentality That Stifles Innovation and Creativity

4. Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy

5. The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptomic, Proteomic, and Genomic Mutational Fraction Differences Based on HPV Status Observed in Patient-Derived Xenograft Models of Penile Squamous Cell Carcinoma;Cancers;2024-03-06

2. Matrix Stiffness Triggers Lipid Metabolic Cross-talk between Tumor and Stromal Cells to Mediate Bevacizumab Resistance in Colorectal Cancer Liver Metastases;Cancer Research;2023-08-23

3. Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy;Frontiers in Oncology;2022-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3